|
Originally published In Press as doi:10.1074/jbc.M105606200 on September 28, 2001
J. Biol. Chem., Vol. 276, Issue 48, 44435-44443, November 30, 2001
GTPases of the Rho Subfamily Are Required for Brucella
abortus Internalization in Nonprofessional Phagocytes
DIRECT ACTIVATION OF Cdc42*
Caterina
Guzmán-Verri §¶,
Esteban
Chaves-Olarte ,
Christoph
von Eichel-Streiber**,
Ignacio
López-Goñi ,
Monica
Thelestam§,
Staffan
Arvidson§,
Jean-Pierre
Gorvel§§, and
Edgardo
Moreno ¶¶
From the Programa de Investigación en
Enfermedades Tropicales, Escuela de Medicina Veterinaria, Universidad
Nacional, P. O. Box 304, 3000 Heredia, Costa Rica, the
§ Microbiology & Tumorbiology Center, Karolinska
Institute, S-17177 Stockholm, Sweden, the Centro de
Investigación en Enfermedades Tropicales, Facultad de
Microbiología, Universidad de Costa Rica, 1000 San José,
Costa Rica, the ** Institut für Medizinische
Mikrobiologie und Hygiene, Verfügungsgebaude für Forschung
und Entwicklung, Johannes Gutenberg-Universität Mainz, Obere
Zahlbacher Straße 63, 55101 Mainz, Federal Republic of Germany, the
 Departamento de Microbiología,
Universidad de Navarra, P. O. Box 177, 31080 Pamplona, Spain, and
§§ INSERM-CNRS, Centre d'Immunologie de
Marseille-Luminy, 13288 Marseille Cedex 9, France
Received for publication, June 18, 2001, and in revised form, September 5, 2001
 |
ABSTRACT |
Members of the genus
Brucella are intracellular -Proteobacteria
responsible for brucellosis, a chronic disease of humans and
animals. Little is known about Brucella virulence
mechanisms, but the abilities of these bacteria to invade and to
survive within cells are decisive factors for causing disease.
Transmission electron and fluorescence microscopy of infected
nonprofessional phagocytic HeLa cells revealed minor membrane changes
accompanied by discrete recruitment of F-actin at the site of
Brucella abortus entry. Cell uptake of B. abortus was negatively affected to various degrees by actin,
actin-myosin, and microtubule chemical inhibitors. Modulators of
MAPKs and protein-tyrosine kinases hampered Brucella cell
internalization. Inactivation of Rho small GTPases using clostridial
toxins TcdB-10463, TcdB-1470, TcsL-1522, and TcdA significantly reduced
the uptake of B. abortus by HeLa cells. In contrast,
cytotoxic necrotizing factor from Escherichia coli, known
to activate Rho, Rac, and Cdc42 small GTPases, increased the
internalization of both virulent and non-virulent B. abortus. Expression of dominant-positive Rho, Rac, and Cdc42
forms in HeLa cells promoted the uptake of B. abortus, whereas expression of dominant-negative forms of these GTPases in HeLa
cells hampered Brucella uptake. Cdc42 was activated upon cell contact by virulent B. abortus, but not by a
noninvasive isogenic strain, as proven by affinity precipitation of
active Rho, Rac, and Cdc42. The polyphasic approach used to discern the molecular events leading to Brucella internalization
provides new alternatives for exploring the complexity of the signals
required by intracellular pathogens for cell invasion.
 |
INTRODUCTION |
Brucellosis is a contagious bacterial disease of animals and a
true zoonosis. It is caused by facultative intracellular organisms of the genus Brucella, composed of six recognized species
with affinity for different hosts (1-4). Infection in humans depends upon contact with infected animals or their products, causing a severe
syndrome that, if left untreated, may lead to disability and death (4).
Despite the fact that the first member of the genus was described more
than 100 years ago, the intracellular life cycle and virulence
mechanisms of Brucella are just being unveiled (5-7). In
comparison with other pathogenic bacteria, Brucella lacks
classical virulence factors such as exotoxins, invasive proteases,
toxic lipopolysaccharide, capsules, virulence plasmids, and lysogenic
phages. Furthermore, it does not generate resistance forms; does not
display antigenic variation; and lacks fimbriae, pili, and flagella
(8). In general, Brucella virulence resides in its well
developed ability to invade, survive, and replicate within vacuolar
compartments of professional and nonprofessional phagocytes (6, 9-14).
In professional phagocytes as well as in caprine M
(lymphoepithelial) cells, Brucella is ingested by a
zipper-like mechanism (15). Opsonized brucellae are internalized via
complement and Fc receptors in macrophages and monocytes, whereas
non-opsonized brucellae seem to penetrate via lectin or fibronectin
receptors, in addition to other unknown receptors (16, 17). In
nonprofessional phagocytes, Brucella appears to be
internalized by receptor-mediated phagocytosis (18, 19). Although
zipper-like phagocytosis has been observed in these cells (7), it seems
to be more an exceptional event than a common phenomenon (18,
20).
Penetration into nonprofessional phagocytes occurs within minutes after
inoculation, with one or two brucellae/cell (6). Cytoskeletal
rearrangements have not been directly observed, but these structures
seem to be required, since various cytoskeletal chemical modulators
hamper the internalization of Brucella in these cells (7,
19). Although the molecular mechanisms underlying these phenomena are
not known, at least one signaling system, BvrR-BvrS, coding for a
regulator (BvrR) and a sensor protein (BvrS) has been implicated in the
invasion of Brucella abortus into cells (14). In the same
vein, the absence of O- and native hapten
polysaccharides on the Brucella surface considerably
hampers bacterial cell invasion (14, 17, 21). These type of
mutations are known to modify the topology and biological properties of the Brucella outer membrane, altering the attachment to
and penetration into host cells (22-24).
The ability of different bacteria to exploit cell signal transduction
pathways and cytoskeletal components to secure their survival is a well
recognized event. Paradigms of host subversion by either intracellular
or extracellular bacteria such as Salmonella, Shigella, Listeria, Neisseria,
Yersinia, and Escherichia have been established
in recent years (25-31). By interacting with cytoskeletal regulators
such as the small GTP-binding proteins of the Rho subfamily, these
bacteria have developed efficient ways to induce cytoskeletal rearrangements. GTPases of the Rho subfamily function as molecular switches that cycle between an active GTP-bound state and an inactive GDP-bound state. Activated proteins of the Rho subfamily interact with
effector molecules to produce biological responses involving actin
reorganization. Some of these responses involve membrane rearrangements
implicated in several functions, one of them being phagocytosis
(32).
To characterize the basic molecular events that proceed after B. abortus binds to nonprofessional phagocytic HeLa cells, several microscopic and biological strategies were followed. Initially, we
employed cytoskeletal chemical modulators in cells previous to
infection. Then, we used bacterial toxins capable of modifying small
GTPases of the Rho family as well as expression of dominant-positive or
dominant-negative GTPase forms in cells during bacterial infection. Finally, we performed direct quantification of activated small GTPases
after infection with B. abortus. The data obtained indicate that B. abortus modulates the host cell cytoskeleton to
induce its internalization.
 |
EXPERIMENTAL PROCEDURES |
Bacterial Strains and Plasmids--
All strains were routinely
grown in tryptic soy or Luria-Bertani medium. B. abortus
2308 NaIr is a wild-type virulent smooth lipopolysaccharide
strain that has been described elsewhere (33). B. abortus
2.13 is a smooth lipopolysaccharide noninvasive 2308 NaIr
derivative with a Tn5 insertion in bvrS (14).
Salmonella typhimurium SL1344 (34) was obtained from
Stéphane Méresse (Centre d'Immunologie de
Marseille-Luminy). Escherichia coli expressing
CNF1; plasmids encoding Myc
epitope-tagged Cdc42V12 and Cdc42N17 derived from pMT90 (from Philipe
Chavrier, Institut Curie-Section Recherche, Paris, France); and
plasmids expressing Myc epitope-tagged RhoAV14, RhoAN19, Rac1V12, and
Rac1N17 derived from pEXV (35, 36) were provided by Gilles Flatau and
Patrice Boquet (INSERM, Nice, France). GST-tagged RBD was expressed
from plasmid pGEX-2T-TRBD (provided by Xiang-Dong Ren and Martin
Alexander Schwartz, Scripps Research Institute, La Jolla, CA) (37).
GST-tagged PBD was expressed from a derivative pGEX-2T plasmid
(obtained from Gary M. Bokoch, Scripps Research Institute) (38).
Cell Culture, Microinjection, and Transfection--
Cells were
grown in Eagle's minimal essential medium supplemented with 5% fetal
bovine serum, 2.5% sodium bicarbonate, and 1% glutamine. Penicillin
(100 units/ml) and streptomycin (100 µg/ml), which were routinely
added, were excluded from cell cultures during Brucella
infections. For cell microinjection, 5 × 105 HeLa
cells were seeded on 13-mm glass slides and incubated for 24 h at
37 °C in 5% CO2. Cells were microinjected
(FemtoJet®, Eppendorf) into the nucleus with the selected
plasmids at a concentration of 1 µg/ml in sterile distilled water and
infected with B. abortus as described below. After a 16-h
incubation in the presence of 5 µg/ml gentamycin, cells were
processed for immunofluorescence. Successfully injected cells and
intracellular bacteria were localized by immunofluorescence using an
anti-Myc antibody (clone 9E-10, Santa Cruz Biotechnology), a
TRITC-conjugated anti-mouse antibody (Sigma), and a bovine
FITC-conjugated anti-Brucella antibody (39). Cell
transfection was carried out in 24-well tissue culture plates using
Lipofectin (Life Technologies, Inc.) according to the manufacturer's instructions. Brucella cell infections were performed as
described below.
Binding and Invasion Assays--
HeLa cells were grown to
subconfluency in 24-well tissue culture plates at 37 °C under 5%
CO2. Chemical cytoskeletal modulators (Sigma) listed in
Table I were present throughout the experiments and used at
concentrations and incubation times according to Rosenshine et
al. (40). The chemical 2,3-butanedione monoxime was used at a
concentration of 7 nM for 30 min (41); PD098059 was used at
a concentration of 50 µM for 40 min (42); and wortmannin was used at a concentration of 50 nM for 30 min (43).
TcdB-10463, TcdB-1470, TcdA, and TcsL-1522 selective toxin inhibitors
of small GTPases were prepared as described (44). E. coli
CNF was purified according to Falzano et al. (45). Unless
otherwise stated, the toxin working concentrations and incubation times
used were as follows: 50 ng/ml TcdB-10463 for 40 min, 50 ng/ml
TcdB-1470 for 40 min, 5 ng/ml TcdA overnight, 1 µg/ml TcsL-1522
overnight, and 3 ng/ml CNF for 2 h. Intoxication of HeLa cells was
always carried out prior to B. abortus infection. After
intoxication, the monolayer was washed once with cold
phosphate-buffered saline (0.01 M, pH 7.4) and kept at
4 °C until infection. Infections were carried out using an overnight
culture of B. abortus diluted in Eagle's minimal essential
medium to reach a concentration of 2.5 × 108 cfu/ml.
The inoculum was then added to the monolayer at a multiplicity of
infection of 500 cfu/ml. For Salmonella control experiments, the multiplicity of infection was 50 cfu/ml. Plates were centrifuged at
300 × g at 4 °C, incubated for 30 min at 37 °C
under 5% CO2, and washed three times with
phosphate-buffered saline. Extracellular bacteria were killed by adding
Eagle's minimal essential medium supplemented with 100 µg/ml
gentamycin for 1 h at 37 °C under 5% CO2. Plates
were then washed with phosphate-buffered saline. HeLa cells were lysed
by adding 0.1% Triton X-100 for 10 min. The samples were collected,
spun, and resuspended in 110 µl of tryptic soy broth. Aliquots were
plated on tryptic soy agar and incubated at 37 °C for 3 days for
determination of cfu.
Immunofluorescence and Transmission Electron Microscopy--
For
immunofluorescence analysis, HeLa cells (5 × 105)
were seeded on 13-mm glass slides, incubated until subconfluent at
37 °C under 5% CO2, and inoculated with bacteria as
described above. After five washing steps with phosphate-buffered
saline, cells were fixed with ice-cold 3% paraformaldehyde (Merck) for
15 min. Samples were washed once and incubated for 10 min with
phosphate-buffered saline containing 50 mM
NH4Cl. Intracellular and extracellular bacteria were
detected and counted as previously described (11). Briefly,
extracellular bacteria were labeled using a FITC-conjugated anti-Brucella antibody diluted 1:250 (in 10% horse serum in
phosphate-buffered saline), followed by washing steps. Intracellular
bacteria were detected by incubating the slides for 30 min with rabbit
anti-B. abortus antiserum (39) diluted 1:250 in 10% horse
serum containing 0.1% saponin (permeabilization step). The cells were
then washed three times with 0.2% Tween 20 and incubated for 30 min
with a TRITC-conjugated anti-rabbit antibody (Jackson ImmunoResearch Laboratories, Inc.) diluted 1:150 in 10% horse serum containing 0.1%
saponin. When needed, FITC-phalloidin (Sigma) was added at this point.
Slides were mounted in Mowiol solution and analyzed by
phase-contrast or fluorescence microscopy. Counts of intracellular and
extracellular bacteria were performed in at least 100 infected cells
and are expressed as the mean ± S.D. of bacteria/cell. The percentage of cells with associated bacteria is expressed as the mean ± S.D. of cells with bound bacteria in five different 40× fields. Statistical analysis was performed using Student's
t test. For transmission electron microscopy, HeLa
monolayers infected with an overnight culture of B. abortus
2308 NaIr were fixed with 2.5% glutaraldehyde and 2%
paraformaldehyde in 0.1 M phosphate buffer. Samples were
placed in 1% OsO4 solution for 1 h for post-fixation,
dehydrated in a graded concentration of ethanol, and infiltrated with
Spurr resin. Thin sections on 300 mesh collodion-coated grids
were stained with uranyl acetate and lead Sato's solution (46).
Preparations were examined with a Hitachi H-7100 electron microscope
operating at 75 kV.
Quantification of GTP-Rho, GTP-Rac, and GTP-Cdc42--
For
precipitation steps, GST-tagged RBD and PBD were purified from cell
lysates of E. coli strains harboring plasmids pGEX-2T-TRBD and pGEX-2T-PBD, respectively, according to Ren et al. (37) and Benard et al. (38). HeLa cells grown in six-well plates were infected for different time intervals with B. abortus
at a multiplicity of infection of 5000 cfu/cell. After incubation, cells were washed with ice-cold phosphate-buffered saline and lysed
with 500 µl of ice-cold precipitation buffer (1% Triton X-100, 0.1%
SDS, 0.3% Nonidet P-40, 500 mM NaCl, 10 mM
MgCl2, and 50 mM Tris, pH 7.2). Lysates were
clarified by centrifugation at 14,000 rpm for 1 min. Twenty µl of
lysate were saved as a control of total GTPase content. GTP-loaded Rho
GTPases were precipitated with Sepharose beads coupled to either
GST-PBD or GST-RBD protein. Samples were incubated for 30 min at
4 °C with shaking, washed with precipitation buffer, and resuspended
in 25 µl of sample buffer for SDS-polyacrylamide gel electrophoresis
analysis (47). Samples transferred to a polyvinylidene difluoride
membrane (Roche Molecular Biochemicals) were tested either with rabbit
antibodies against Rho or Cdc42 (Santa Cruz Biotechnology) or with an
anti-Rac monoclonal antibody (Transduction Laboratories). Probing and
developing were performed with peroxidase-labeled secondary antibodies
and with a chemiluminescence Western blotting kit (Pierce SuperSignal West Dura), respectively. GTP-Cdc42, GTP-Rho, and GTP-Rac levels were
calculated using Scion Image for Windows and compared with control
total Cdc42, Rho, and Rac.
 |
RESULTS |
Host Cell Cytoskeleton Responds to B. abortus Contact--
To
assess the role of the host cell cytoskeleton in Brucella
internalization, HeLa cells were infected with bacteria and analyzed by
transmission electron and immunofluorescence microscopy. In agreement
with previous investigations (11, 48), few cells in a monolayer had
associated bacteria (see below). At 30 min of infection, bacteria were
mostly located in cell-cell contacts rather than in the cell body (see
below). Minor host cell membrane projections were observed upon contact
with bacteria (Fig. 1A). Under
these experimental conditions, zipper-like phagocytosis was not
observed, despite that a considerable number of intracellular brucellae
were already found within vacuoles, as previously reported (6). When
infected cells were stained with FITC-phalloidin, a discrete
rearrangement of the actin cytoskeleton was observed at the site of
contact between Brucella and its host cell (Fig. 1,
B-D). To further identify eukaryotic components required
for B. abortus uptake, HeLa cells were treated with
different cytoskeletal and signal transduction modulators before
infection with B. abortus. Inhibition of the eukaryotic
microtubule network with colchicine or nocodazole reduced
Brucella internalization to 40 and 10%, respectively,
compared with non-intoxicated cells (Fig.
2). Treatment of cells with drugs
affecting the actin cytoskeleton also impaired internalization.
Particularly, cytochalasin D almost abrogated Brucella
uptake. These results are in agreement with the observations made by
electron and fluorescence microscopy, indicating participation of the
host actin cytoskeleton in Brucella uptake. When tyrosine kinase inhibitors such as tyrphostin and genistein were used, the
percentages of internalized bacteria were reduced to 10 and 20%,
respectively, compared with untreated cells. Pretreatment of HeLa cells
with the MAPK kinase inhibitor PD098059 resulted in a 50% decrease in
bacterial invasion, whereas pretreatment with the phosphatidylinositol
3-kinase inhibitor wortmannin reduced Brucella
internalization to 10%. S. typhimurium SL1344 was included as a control of our test system. Fig. 2 demonstrates that the effects
induced by the various chemicals modulators were similar to those
reported elsewhere for Salmonella (Table
I).

View larger version (134K):
[in this window]
[in a new window]
|
Fig. 1.
B. abortus induces minor
cytoskeletal rearrangements in HeLa cells. A,
transmission electron microscopy of B. abortus entry into
HeLa cells reveals discrete cellular projections at the site of contact
between the cell and bacterium (arrow). Bar = 0.4 µm. B-D, double immunofluorescence analysis of
F-actin and extracellular B. abortus bound to HeLa cells. In
B, the arrow points to B. abortus
immunolabeled with rabbit anti-Brucella antiserum
and TRITC-conjugated anti-rabbit IgG serum after cell infection. In
C, the arrow points to foci of actin
polymerization stained with FITC-phalloidin. In D, the
superimposition of B and C demonstrates
colocalization of B. abortus and actin rearrangement.
|
|

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 2.
B. abortus internalization is
impaired by chemical cytoskeletal modulators. HeLa cells were
treated with different chemical drugs and then infected with B. abortus (black bars) or S. typhimurium
(white bars). The effect on bacteria uptake was assessed
using the gentamycin survival assay as described under "Experimental
Procedures." Mean values of one representative experiment from at
least three independent assays were normalized relative to the cfu
obtained in infected non-intoxicated cells.
|
|
B. abortus Internalization Is Affected by Modulation of GTPase
Activity by Bacterial Toxins--
Clostridial toxins TcdB-10463,
TcdB-1470, TcsL-1522, and TcdA have been described as
glucosyltransferases targeting different members of the Rho and Ras
subfamilies of small GTPases (49, 50). They efficiently block the
interaction of Rho and Ras protein subfamilies with their effectors,
leading to functionally inactive GTPases (51). On the other hand, CNF
from E. coli exerts the opposite effect, i.e.
activation of Rho GTPases (52, 53). Since these toxins are very
specific for different small GTPases involved in cytoskeleton functions
such as membrane ruffling, lamellipodia and stress fiber formation (51,
54), they can be used to study the role of Rho proteins in the
internalization of different pathogens (55, 56). HeLa cells treated for
40 min with TcdB-10463 and TcdB-1470 or overnight with TcdA and
TcsL-1522 exhibited decreased Brucella internalization
compared with untreated cells (Fig.
3A). In contrast, when cells
were treated with CNF for 2 h, an ~10-fold increase in
internalization was obtained compared with untreated cells (Fig.
3B). We concluded from these experiments that some of the
toxin targets outlined in Fig. 3 are relevant for Brucella
uptake. Because Rho proteins have been implicated in the regulation of
the actin cytoskeleton, it was important to determine whether the
observed inhibitory effect was due to the direct action of the toxins
on Rho proteins or to a secondary effect inducing actin
depolymerization. HeLa cells were treated with a constant dose of toxin
for different time periods and infected with B. abortus. A
marked reduction in Brucella uptake was seen already after
15 min of intoxication with TcdB-10463 and TcdB-1470 compared with
untreated cells (Fig. 4A).
Since a cytopathic effect was not evident until 30-45 min of
intoxication, we concluded that the reduced internalization of
Brucella was not caused by secondary actin depolymerization.
With CNF, increased internalization was observed after 1 h
treatment, with a peak at 2-3 h. Membrane ruffling was evident after
2 h of treatment (Fig. 4B). The percentage of
internalization dramatically decreased after 3 h, probably due to
secondary effects such as unavailability of free actin monomers.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 3.
Uptake of B. abortus by HeLa
cells treated with different bacterial toxins. A,
gentamycin survival assay of cells treated with different clostridial
toxins; B, gentamycin survival assay of cells treated with
CNF. Mean values of one representative experiment from at least three
independent assays were normalized relative to the cfu obtained in
infected non-intoxicated cells.
|
|

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 4.
Effect on B. abortus uptake
in TcdB- or CNF-intoxicated HeLa cells occurs before cytopathic effect
is evident. A, gentamycin survival assay using
TcdB-1470- or TcdB-10463-treated HeLa cells at different time periods;
B, gentamycin survival assay using CNF-intoxicated HeLa
cells at different time periods. The arrows indicate the
first time that cytopathic effect was evident. Bacteria were incubated
with cells after toxin treatment at each time point.
|
|
CNF (but Not TcdB) Cell Intoxication Affects Adhesion of B. abortus--
Successful bacterial invasion depends on two consecutive
steps: binding and internalization (57). Inhibition or promotion of
B. abortus uptake in toxin-treated cells compared with
non-intoxicated cells may be due to altered binding and/or
internalization. To distinguish between these possibilities, double
immunofluorescence to resolve intracellular from extracellular bacteria
in cells treated with TcdB-10463 and CNF was performed, and counts were compared with infected non-intoxicated cells (Fig.
5). Binding was not affected by
intoxication with TcdB-10463 for 15 min since the mean number of
bacteria/cell was not significantly different between non-intoxicated
and intoxicated cells (p > 0.05). However, the
proportion of extracellular to intracellular bacteria was higher in
treated cells (p < 0.05) (Fig. 5A,
panel a). At 40 min of intoxication, 100% of the cells
exhibited some degree of typical arborizing cytopathic effect induced
by this toxin (Fig. 5B, panel b,
TcdB-10463) as described previously (58). Under these
conditions, bacteria were found mainly at the edges of the cell body,
whereas in control cells, they were found in cell-cell contacts (Fig. 5B, panels a-c, Control, and
TcdB-10463). Since body retraction is more evident in these
intoxicated cells, it was easier to observe the preferential binding of
bacteria to the remaining cell-cell contacts. After 40 min of
intoxication with TcdB-10463, the mean number of bacteria/cell was not
significantly different (p > 0.05) from that in
control cells (Fig. 5A, panel a), and the
proportion of extracellular bacteria was even higher than in cells
intoxicated for 15 min. It has been reported that the percentage of
B. abortus-infected cells in HeLa cell monolayers is <50%
(11, 48). We therefore analyzed whether this percentage is somehow
modified in intoxicated HeLa cells. Fig. 5A (panel
c) shows that the percentage of cells associated with bacteria in
TcdB-10463-treated monolayers was lower than in non-intoxicated
monolayers. In our experiments, the percentages ranged from 10 to 20%
in infected non-intoxicated cells and were 6.5 and 3.6% in monolayers
treated with TcdB-10463 for 15 and 40 min, respectively, showing that
toxin treatment decreases infection. Altogether, these results indicate
that binding of B. abortus to HeLa cells is not
significantly affected by TcdB-10463 intoxication. However,
internalization is reduced because less bacteria were taken up per
cell, and less cells in the monolayer had associated bacteria. Similar
experiments were performed in CNF-treated HeLa cells. Membrane ruffling
was recorded after 2 h of intoxication, and bacteria were observed
on the cell body (Fig. 5B, panels a-c,
CNF), particularly close to ruffles. Electron transmission
microscopy of CNF-treated HeLa cells infected with Brucella
indicated that the bacteria were able to penetrate through membrane
ruffles, when present (data not shown). Adhesion of virulent B. abortus 2308 to HeLa cells was promoted by CNF treatment compared with untreated cells (p < 0.05) (Fig. 5A,
panel b). However, the proportion of intracellular and
extracellular bacteria did not differ between control and intoxicated
cells (p > 0.05). The increased binding was not
specific for the virulent strain because the internalization-deficient strain, 2.13 (14), also bound more to CNF-treated cells than to
untreated cells (p < 0.05). With strain 2.13, however,
the ratio of intracellular to extracellular bacteria was increased because more bacteria were found intracellularly (Fig. 5A,
panel b). Therefore, CNF-intoxicated HeLa cells promoted
both binding and internalization of non-virulent strain 2.13. With
virulent strain 2308, no difference in the ratio of intracellular to
extracellular bacteria was observed after 30 min of incubation, despite
the fact that binding was promoted. On the other hand, the percentage of cells associated with bacteria was significantly higher
(p < 0.01) in CNF-treated cells for both the virulent
and non-virulent B. abortus strains (Fig. 5A,
panel d). In conclusion, CNF treatment of HeLa cells
promotes greater Brucella binding per cell and
increases the number of cells with associated bacteria, leading to an
overall more efficient invasion of the cell monolayer.

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 5.
Adhesion of virulent B. abortus
to HeLa cells is not affected by TcdB-10463, but is promoted in
CNF-intoxicated HeLa cells. A, HeLa cells were
intoxicated with TcdB-10463 for 15 (15') or 40 (40') min or with CNF for 2 h, infected with B. abortus for 30 min, and then extracellular (black bars)
and intracellular (white bars) bacteria were counted by
double immunofluorescence analysis. Panel a, total number
and proportion of intracellular/extracellular bacteria/cell in
TcdB-10463-intoxicated and non-intoxicated HeLa monolayers; panel
b, total number and proportion of intracellular/extracellular
bacteria/cell in CNF-intoxicated and non-intoxicated cells for both the
virulent B. abortus 2308 and nonpathogenic 2.13 strains;
panel c, number of cells with associated bacteria in
TcdB-10463-intoxicated and non-intoxicated HeLa cells; panel
d, number of cells with associated bacteria in CNF-treated and
untreated HeLa cells. Counts of intracellular and extracellular
bacteria were performed in at least 100 infected cells and are
expressed as the mean of bacteria/cell obtained from one representative
experiment of three independent assays. The percentage of cells with
associated bacteria is expressed as the mean of cells with bound
bacteria in five different 40× fields. The results presented are from
one experiment of at least two independent assays. B, HeLa
cells were intoxicated with TcdB-10463 for 40 min or with CNF for
2 h, infected with B. abortus for 30 min, and then
processed for immunofluorescence. Panels a, extracellular
bacteria immunolabeled with an FITC-conjugated anti-Brucella
antibody; panels b, bacterial toxin cytopathic effect
showing spikes in TcdB-10463-treated cells (TcdB-10463,
arrows) and ruffles in CNF-intoxicated cells
(CNF, arrow) as revealed by phase-contrast
microscopy; panels c, superimposed images showing B. abortus attached to spikes of TcdB-10463-treated cells
(TcdB-10463, arrows) or several bacteria bound to
CNF-treated cells displaying membrane ruffles (CNF,
arrows). Bacteria lying between the boundaries of cell-cell
contacts (Control, arrow) are shown.
|
|
B. abortus Internalization Is Affected by the Expression of
Dominant-positive or Dominant-negative Rho GTPases--
To further
investigate the role of small GTPases in Brucella uptake,
infections of HeLa cells expressing active forms of Rho, Rac, and Cdc42
were performed. HeLa cells were microinjected with plasmids encoding
Myc-tagged dominant-positive mutants of Rho, Rac, and Cdc42. B. abortus 2308 was incubated for 30 min, followed by the addition of
gentamycin to kill extracellular bacteria. After 16 h of
gentamycin incubation, when bacterial replication is still not evident
in control cells (6), infected monolayers were processed for
immunofluorescence. Expression of the corresponding mutant Rho protein
was verified using immunofluorescently labeled anti-Myc antibodies as
shown in Fig. 6A. The number
of intracellular bacteria/cell increased in cells expressing positive
mutant Rac and Rho (but not Cdc42) compared with control cells (Fig.
6B, panel a). However, the percentage of cells
with internalized bacteria increased in all cases (Fig. 6B,
panel b). As expected, the expression of dominant-negative
mutant Rho proteins (RhoAN19, Rac1N17, and Cdc42N17) in transfected
HeLa cells inhibited the internalization of this bacterium to different
extents (Fig. 7), supporting a role for
these small GTPases in Brucella uptake.

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 6.
B. abortus internalization is
enhanced in HeLa cells expressing dominant-positive mutants of small
GTPases. A, HeLa cells were microinjected with a
plasmid encoding the Myc-RhoAV14 fusion protein and infected with
B. abortus for 30 min. Cells were then fixed, permeabilized,
and processed for double immunofluorescence. Panel a,
microinjected cells had an altered morphology and were evident after
immunolabeling using a monoclonal anti-Myc antibody and a
TRITC-conjugated anti-mouse antibody. Panel b, shown are
immunolabeled bacteria using a FITC-conjugated anti-Brucella
antibody. Panel c, merged panels a and
b demonstrate colocalization of transformed cells with
Brucella. Similar results were obtained when HeLa cells were
microinjected with plasmids encoding the Myc-Rac1V12 and Myc-Cdc42V12
fusion proteins (data not shown). B, shown are the number of
bacteria/cell and proportion of cells with intracellular bacteria in
cells expressing dominant-positive mutants of small GTPases.
Panel a, mean number of intracellular bacteria/cell found in
at least 150 microinjected cells. Panel b, percentage of
cells expressing different dominant-positive mutants with intracellular
bacteria. The results presented are from one experiment of at least two
independent assays.
|
|

View larger version (7K):
[in this window]
[in a new window]
|
Fig. 7.
Expression of dominant-negative mutants of
small GTPases in HeLa cells decreases B. abortus
internalization. HeLa cells were transfected with plasmids
encoding the Myc-RhoAN19, Myc-Rac1N17, and Myc-Cdc42N17 fusion proteins
and infected with the virulent B. abortus 2308 strain. The
gentamycin survival assay was then performed. Mean values are
normalized relative to the cfu obtained in non-transfected cells. The
results presented are from one experiment of at least two independent
assays.
|
|
Cdc42 Is Directly Activated by Virulent (but Not by
Non-virulent) B. abortus--
The experiments described above
indicated that active Rho, Rac, and Cdc42 promote Brucella
uptake by HeLa cells. However, it was important to establish whether
binding of B. abortus to HeLa cells leads to direct
activation of any of the Rho proteins. Lysates from cells infected with
either the virulent 2308 or noninvasive 2.13 strain were incubated with
beads bearing the Rho effector RBD or the Rac and Cdc42 effector PBD,
according to the affinity capture systems developed by Ren et
al. (37) and Benard et al. (38), respectively. After
protein elution, samples were analyzed by Western blotting using
anti-RhoA, anti-Rac, or anti-Cdc42 antibodies. Fig.
8A shows that no difference in
Rho or Rac activation was detected up to 60 min of infection with the
virulent 2308 strain. On the contrary, increased levels of GTP-Cdc42
(up to 4-fold) were detected at 30 min of infection (Fig.
8B). Cdc42 activation was specific for the virulent strain
since the internalization-deficient 2.13 strain did not activate Cdc42
up to 60 min after infection. We therefore concluded that early direct
Cdc42 activation is biologically important for successful B. abortus internalization.

View larger version (49K):
[in this window]
[in a new window]
|
Fig. 8.
Virulent B. abortus strain
2308 activates Cdc42 in HeLa cells. A, analysis
of activated Rho, Rac, and Cdc42 using affinity precipitation at
different times of infection of HeLa cells with virulent B. abortus strain 2308 or the isogenic noninvasive mutant strain
2.13. Samples were separated by SDS-polyacrylamide gel electrophoresis,
blotted, and immunodetected with anti-Rho, anti-Rac, or anti-Cdc42
antibodies. In the zero time point sample, tryptic soy broth was added
to the cells. Samples from lysates were run in parallel on
SDS-polyacrylamide gel and immunoblotted using specific anti-small
GTPase antibodies to determine the total amount of each GTPase.
Increased levels of GTP-Cdc42 were detected after 30 min of infection
with the virulent 2308 strain. No differences in the quantities of
GTP-Rho and GTP-Rac were detected upon Brucella infection.
B, quantification of Cdc42-GTP levels upon cell interaction
with the virulent 2308 ( ) and non-virulent 2.13 ( ) B. abortus strains compared with the negative control. One
representative experiment from three different assays is
presented.
|
|
 |
DISCUSSION |
Different attempts have been made to characterize the
host-parasite interactions that prevail during Brucella
entry into eukaryotic cells. Pathological and microscopic studies have
been reported (15, 18, 59, 60), but the molecular mechanisms involved in the process have not been properly addressed. Evident membrane rearrangements have been described upon Brucella infection
of caprine M (lymphoepithelial) cells and macrophages (15, 20). Our
electron microscopy studies confirmed the results obtained earlier (7,
18), where only slight membrane rearrangements were found at the site
of virulent smooth lipopolysaccharide Brucella entry
into nonprofessional phagocytes. Moreover, phalloidin staining demonstrated a modest recruitment of the F-actin cytoskeleton at the
site of attachment. The participation of the actin cytoskeleton was
further indicated by reduced internalization of Brucella
after treatment of HeLa cells with the actin-depolymerizing agent
cytochalasin D or with the myosin inhibitor 2,3-butanedione monoxime.
Although less dramatic than cytochalasin D, microtubule-depolymerizing agents also hampered the invasion of Brucella into cells.
Other investigators have arrived at similar conclusions using
cytoskeletal inhibitors (7, 19). However, it must be pointed out that this inhibition could be the result of the indirect microtubule inhibitor effect on the MAPK pathway (61-64), which is required for
Brucella internalization, as shown here.
Uptake of different bacteria depends on the actin cytoskeleton
(65-75). Although examples of bacteria requiring only the microtubule network for successful internalization are rare (76), there are many
bacteria that recruit both microtubules and microfilaments (77-84). In
this respect, B. abortus appears to belong to the latter group. Given the growing evidence for potential interactions between the microtubule and actin networks, it is feasible that pathogens exploiting one network would also be dependent on the other (85-87). Involvement of host kinases, particularly protein-tyrosine kinases, in
Brucella internalization was suggested by the reduced
internalization of bacteria by HeLa cells intoxicated with
protein-tyrosine kinase-specific drugs such as tyrphostin and
genistein. Furthermore, according to the results obtained with
PD098059-intoxicated cells, the ERK pathway also appears to be required
for Brucella uptake to some extent, indicating that
Brucella is able to trigger a response in its host cell upon
contact. Phosphatidylinositols are also involved in this process, as
suggested by the decreased entry of B. abortus into cells
pretreated with wortmannin. Phosphatidylinositol 3-kinase has been
shown to be both an upstream and downstream effector of small GTPases
(88-90), affecting actin polymerization that eventually could lead to
a GTPase-dependent Brucella internalization event. A converging molecule for all the pathways studied herein is
Ras, a small GTPase activated upon ligand binding to its membrane receptor (particularly tyrosine kinase receptors), coupling
intracellular signal transduction pathways to changes in the external
environment. There is enough evidence to select the Raf-MEK-MAPK
pathway as a key effector in Ras signaling (54). On the other hand,
phosphatidylinositol 3-kinase can bind to GTP-Ras (91), and there is
evidence that Ras and Rho GTPases interact and are activated in series
(32). It would then be relevant to test whether Ras is needed for
Brucella invasion. According to the results obtained with
the chemical drugs, this transduction pathway could be similar to the
one exploited by Listeria, which appears to be different
from the one used by Salmonella (Table I). This idea is in
agreement with the slight actin recruitment induced by
Listeria and Brucella, but not by Salmonella, which induces a major recruitment (26, 67,
69).
Gentamycin survival assays using bacterial toxin-treated cells
demonstrated that Rho, Rac, and Cdc42 are needed for efficient Brucella internalization. This is also supported by the
reduction of bacteria entry into cells expressing dominant-negative
mutants of Rho, Rac, and Cdc42 GTPases. Cdc42 (but not Rac or Rho) was directly activated upon B. abortus contact with host cells,
an event exclusively observed with the virulent strain. Since some clostridial toxins affecting Brucella invasion do not use
Cdc42 as substrate, it is feasible to conclude the participation of other GTPases from these experiments. In this sense, it is possible that Brucella does not directly activate Rho and Rac as well
as other Ras proteins, but takes advantage of activated GTPase pools kept in cells under normal conditions. The increase in B. abortus uptake observed after cell treatment with CNF and the
significant increase observed in cells microinjected with positive
forms of Rac and Rho support this asseveration. Nevertheless, other
GTPases such as Ral and Rap, implicated in endocytosis (92-94), could
be involved in the internalization process as well.
It is important to point out that both TcdB-10463 and TcdB-1470 use the
same cell receptor and display very similar enzymatic parameters during
cell intoxication. However, these two toxins differ in their substrate
preference (49): although TcdB-10463 modifies Rho, Rac, and
Cdc42, TcdB-1470 uses Rac as the only member of the Rho subfamily.
B. abortus internalization is affected earlier by TcdB-10463
intoxication than by TcdB-1470 intoxication as shown by the time curves
obtained with these two toxins. Whereas this observation supports the
participation of the three GTPases from the Rho subfamily during
B. abortus internalization, the almost 100% inhibition of
B. abortus by TcdB-1470 at later times reflects the
importance of Rac. Indeed, Rac has recently been described as a
potential link between the microtubule and actin networks since
microtubule growth induces Rac activation and therefore lamellipodium
formation (87).
The results obtained from the intoxication time curves prove that not
only the toxin kinetics, but also the physiology of the small GTPases
should be taken into account when using this kind of tool. Once bound
to their target, the toxins block Rho GTPases in either a GTP- or
GDP-bound state. In each of these states, these GTPases have different
downstream effects that are time-dependent. It is important
to evaluate the intoxication output at early times, when the direct
effects of the toxins on their Rho targets are more likely to be
observed than the downstream effects of the small GTPase-intoxicated
state. This is clearly exemplified by CNF-treated cells for periods
longer than 3 h (Fig. 4B).
Binding of B. abortus to HeLa cells was not affected
by TcdB-10463 treatment for 15 or 40 min. However, according to the
gentamycin survival assay, TcdB-10463 treatment for 40 min affected
B. abortus uptake. Double immunofluorescence experiments
indicated that bacteria were binding to cells, but fewer numbers were
internalized, and fewer numbers of cells had associated bacteria,
explaining this phenomenon. CNF cell intoxication affected
Brucella invasion in different ways: (i) increased binding
of bacteria per cell, with an absolute increase in intracellular
bacteria; (ii) increased internalization in the case of the B. abortus 2.13 mutant strain, with more intracellular bacteria than
in control experiments; and (iii) increased percentage of cells
permissive to B. abortus internalization. The 10-fold
increase in internalization observed in the gentamycin survival assay
should be the sum of these events, where probably the augmented number
of infected cells has a major contribution. This permissibility event
is affected by toxin treatment, suggesting that GTPases of the Rho
subfamily might have either a direct or indirect role, perhaps by
controlling the formation of cell-cell contacts where B. abortus binds or by regulating the expression of a protein
particularly found in these regions and required for bacteria to bind.
More studies are needed to clarify why bacteria are found mainly in
cell-cell contacts and why some cells in the same monolayer are more
permissive to B. abortus invasion than others, an event also
described for Campylobacter jejuni and Listeria
(95, 96).
B. abortus cell uptake may induce a particular signal
transduction pathway where small GTPases are activated in series.
Indeed, Ras has been reported as a Cdc42 activator, and Cdc42 itself
has been described as a Rac activator, whereas Rac activates or
inhibits Rho to varying degrees (88, 97, 98). Although the events leading to Brucella internalization may follow a similar
GTPase activation pathway, this may be a simple view of a more
intricate set of signals occurring during the invasion of intracellular pathogens into cells.
 |
ACKNOWLEDGEMENTS |
We thank Enrique Freer and Maribelle Vargas
(Electron Microscopy Unit, University of Costa Rica) for help with the
electron transmission microscopy studies and Daphnne Garita for
technical assistance.
 |
FOOTNOTES |
*
This work was supported in part by Research Contract
ICA4-CT-1999-10001 from the European Community, Research and
Technological Development Projects NOVELTARGETVACCINES, Ministerio de
Ciencia y Tecnología/Consejo Nacional de Ciencia y
Tecnología (Costa Rica), Vicerrectoría de
Investigación from the Universidad de Costa Rica, American
Society for Microbiology Microbial Resources Center award, and
Grant AGL2000-0305-C02-01 from the Ministerio de Ciencia y
Tecnología (Spain).The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
Recipient of a grant from the Swedish International
Development Agency as part of the Karolinska International
Research Training Program.
¶¶
To whom correspondence should be addressed. Tel.:
506-2380761; Fax: 506-2381298; E-mail:
emoreno@ns.medvet.una.ac.cr.
Published, JBC Papers in Press, September 28, 2001, DOI 10.1074/jbc.M105606200
 |
ABBREVIATIONS |
The abbreviations used are:
CNF, cytotoxic
necrotizing factor from E. coli;
GST, glutathione
S-transferase;
RBD, Rhotekin Rho-binding domain;
PBD, GTPase-binding domain of p21-activated kinase-1;
FITC, fluorescein
isothiocyanate;
cfu, colony-forming units;
MAPK, mitogen-activated
protein kinase;
ERK, extracellular signal-regulated kinase;
TRITC, tetramethylrodamine isothiocyanate;
TcdB, Clostridium
difficile toxin B;
TcdA, C. difficile toxin A;
TcsL, C. sordellii lethal toxin.
 |
REFERENCES |
| 1.
|
Corbel, M. J.,
and Brinley-Morgan, W. J.
(1984)
in
Bergey Manual of Systematic Bacteriology
(Krieg, N. K.
, and Holt, J. G., eds), Vol. 1
, pp. 377-388, Williams and Wilkins Co., Baltimore
|
| 2.
|
Corbel, M. J.
(1997)
J. Med. Microbiol.
46,
101-103
|
| 3.
|
Walker, R. L.
(1999)
in
Veterinary Microbiology
(Hirsh, D. C.
, and Zee, Y. C., eds)
, pp. 196-203, Blackwell Scientific Publications, Inc., Malden, MA
|
| 4.
|
Young, E. J.
(1995)
Clin. Infect. Dis.
21,
283-289
|
| 5.
|
Merésse, S.,
Steele-Mortimer, O.,
Moreno, E.,
Desjardins, M.,
Finlay, B.,
and Gorvel, J.-P.
(1999)
Nat. Cell Biol.
1,
E183-E188
|
| 6.
|
Pizarro-Cerdá, J.,
Meresse, S.,
Parton, R. G.,
van der Goot, G.,
Sola-Landa, A.,
López-Goñi, I.,
Moreno, E.,
and Gorvel, J.-P.
(1998)
Infect. Immun.
66,
5711-5724
|
| 7.
|
Pizarro-Cerdá, J.,
Moreno, E.,
and Gorvel, J.-P.
(1999)
in
Advances in Cell and Molecular Biology of Membranes and Organelles
(Tartakoff, A.
, and Gordon, S., eds), Vol. 6
, pp. 201-232, Jai Press Inc., Greenwich, CT
|
| 8.
|
Ugalde, R. A.
(1999)
Microb. Infect.
1,
1211-1219
|
| 9.
|
Comerci, D. J.,
Pollevick, G. D.,
Vigliocco, A. M.,
Frasch, A. C.,
and Ugalde, R. A.
(1998)
Infect. Immun.
66,
3862-3866
|
| 10.
|
Comerci, D. J.,
Martínez-Lorenzo, M. J.,
Sieira, R.,
Gorvel, J.-P.,
and Ugalde, R. A.
(2001)
Cell. Microbiol.
3,
159-168
|
| 11.
|
Pizarro-Cerdá, J.,
Moreno, E.,
Sanguedolce, V.,
Mege, J. L.,
and Gorvel, J.-P.
(1998)
Infect. Immun.
66,
2387-2392
|
| 12.
|
Pizarro-Cerdá, J.,
Moreno, E.,
and Gorvel, J.-P.
(2000)
Microb. Infect.
2,
829-835
|
| 13.
|
Porte, F.,
Liautard, J. P.,
and Kohler, S.
(1999)
Infect. Immun.
67,
4041-4047
|
| 14.
|
Sola-Landa, A.,
Pizarro-Cerdá, J.,
Grillo, M. J.,
Moreno, E.,
Moriyón, I.,
Blasco, J. M.,
Gorvel, J.-P.,
and López-Goñi, I.
(1998)
Mol. Microbiol.
29,
125-138
|
| 15.
|
Ackermann, M. R.,
Cheville, N. F.,
and Deyoe, B. L.
(1988)
Vet. Pathol.
25,
28-35
|
| 16.
|
Campbell, G. A.,
Adams, L. G.,
and Sowa, B. A.
(1994)
Vet. Immunol. Immunopathol.
41,
295-306
|
| 17.
|
Harmon, B. G.,
Adams, L. G.,
and Frey, M.
(1988)
Am. J. Vet. Res.
49,
1092-1097
|
| 18.
|
Detilleux, P. G.,
Deyoe, B. L.,
and Cheville, N. F.
(1990)
Vet. Pathol.
27,
317-328
|
| 19.
|
Detilleux, P. G.,
Deyoe, B. L.,
and Cheville, N. F.
(1991)
Am. J. Vet. Res.
52,
1658-1664
|
| 20.
|
Kusumawati, A.,
Cazevieille, C.,
Porte, F.,
Bettache, S.,
Liautard, J. P.,
and Sri Widada, J.
(2000)
Microb. Pathog.
28,
343-352
|
| 21.
|
Stevens, M. G.,
Olsen, S. C.,
Pugh, G. W.,
and Palmer, M. V.
(1994)
Infect. Immun.
62,
3206-3212
|
| 22.
|
Martínez de Tejada, G.,
Pizarro-Cerdá, J.,
Moreno, E.,
and Moriyón, I.
(1995)
Infect. Immun.
63,
3054-3061
|
| 23.
|
Freer, E.,
Moreno, E.,
Moriyón, I.,
Pizarro-Cerdá, J.,
Weintraub, A.,
and Gorvel, J.-P.
(1996)
J. Bacteriol.
178,
5867-5876
|
| 24.
|
Freer, E.,
Pizarro-Cerdá, J.,
Weintraub, A.,
Bengoechea, J. A.,
Moriyón, I.,
Hultenby, K.,
Gorvel, J.-P.,
and Moreno, E.
(1999)
Infect. Immun.
67,
6181-6186
|
| 25.
|
Jerse, A. E.,
and Rest, R. F.
(1997)
Trends Microbiol.
5,
217-221
|
| 26.
|
Cossart, P.,
and Lecuit, M.
(1998)
EMBO J.
17,
3797-3806
|
| 27.
|
Cornelis, G. R.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
8778-8783
|
| 28.
|
Celli, J.,
Deng, W.,
and Finlay, B. B.
(2000)
Cell. Microbiol.
2,
1-9
|
| 29.
|
Galán, J. E.,
and Zhou, D.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
8754-8761
|
| 30.
|
Nhieu, G. T. V.,
Bourdet-Sicard, R.,
Dumenil, G.,
Blocker, A.,
and Sansonetti, P. J.
(2000)
Cell. Microbiol.
2,
187-193
|
| 31.
|
Frischknecht, F.,
and Way, M.
(2001)
Trends Cell Biol.
11,
30-38
|
| 32.
|
Bar-Sagi, D.,
and Hall, A.
(2000)
Cell
103,
227-238
|
| 33.
|
Sangari, F.,
and Agüero, J.
(1991)
Microb. Pathog.
11,
443-446
|
| 34.
|
Francis, C. L.,
Starnbach, M. N.,
and Falkow, S.
(1992)
Mol. Microbiol.
6,
3077-3087
|
| 35.
|
Qiu, R. G.,
Chen, J.,
McCormick, F.,
and Symons, M.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
11781-11785
|
| 36.
|
Qiu, R. G.,
Chen, J.,
Kirn, D.,
McCormick, F.,
and Symons, M.
(1995)
Nature
374,
457-459
|
| 37.
|
Ren, X. D.,
Kiosses, W. B.,
and Schwartz, M. A.
(1999)
EMBO J.
18,
578-585
|
| 38.
|
Benard, V.,
Bohl, B. P.,
and Bokoch, G. M.
(1999)
J. Biol. Chem.
274,
13198-13204
|
| 39.
|
Rojas, N.,
Freer, E.,
Weintraub, A.,
Ramírez, M.,
Lind, S.,
and Moreno, E.
(1994)
Clin. Diagn. Lab. Immunol.
1,
206-213
|
| 40.
|
Rosenshine, I.,
Ruschkowski, S.,
and Finlay, B. B.
(1994)
Methods Enzymol.
236,
467-476
|
| 41.
|
Herrmann, C.,
Wray, J.,
Travers, F.,
and Barman, T.
(1992)
Biochemistry
31,
12227-12232
|
| 42.
|
Alessi, D. R.,
Cuenda, A.,
Cohen, P.,
Dudley, D. T.,
and Saltiel, A. R.
(1995)
J. Biol. Chem.
270,
27489-27494
|
| 43.
|
Ireton, K.,
Payrastre, B.,
Chap, H.,
Ogawa, W.,
Sakaue, H.,
Kasuga, M.,
and Cossart, P.
(1996)
Science
274,
780-782
|
| 44.
|
von Eichel-Streiber, C.,
Harperath, U.,
Bosse, D.,
and Hadding, U.
(1987)
Microb. Pathog.
2,
307-318
|
| 45.
|
Falzano, L.,
Fiorentini, C.,
Donelli, G.,
Michel, E.,
Kocks, C.,
Cossart, P.,
Cabanie, L.,
Oswald, E.,
and Boquet, P.
(1993)
Mol. Microbiol.
9,
1247-1254
|
| 46.
|
Robinson, D. G., Ehlers, U., Herken, R., Hermann, B., Mayer, F., and Schurmann, F. W.
(eds)
(1987)
Methods of Preparation for Electron Microscopy
, pp. 69-71, Springer-Verlag, Berlin
|
| 47.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685
|
| 48.
|
Detilleux, P. G.,
Deyoe, B. L.,
and Cheville, N. F.
(1990)
Infect. Immun.
58,
2320-2328
|
| 49.
|
Chaves-Olarte, E.,
Low, P.,
Freer, E.,
Norlin, T.,
Weidmann, M.,
von Eichel-Streiber, C.,
and Thelestam, M.
(1999)
J. Biol. Chem.
274,
11046-11052
|
| 50.
|
Aktories, K.,
Schmidt, G.,
and Just, I.
(2000)
Biol. Chem.
381,
421-426
|
| 51.
|
Thelestam, M.,
and Chaves-Olarte, E.
(2000)
Curr. Top. Microbiol.
250,
85-96
|
| 52.
|
Flatau, G.,
Lemichez, E.,
Gauthier, M.,
Chardin, P.,
Paris, S.,
Fiorentini, C.,
and Boquet, P.
(1997)
Nature
387,
729-733
|
| 53.
|
Schmidt, G.,
Sehr, P.,
Wilm, M.,
Selzer, J.,
Mann, M.,
and Aktories, K.
(1997)
Nature
387,
725-729
|
| 54.
|
Scita, G.,
Tenca, P.,
Frittoli, E.,
Tocchetti, A.,
Innocenti, M.,
Giardina, G.,
and Di Fiore, P. P.
(2000)
EMBO J.
19,
2393-2398
|
| 55.
|
Procyk, K. J.,
Kovarik, P.,
von Gabain, A.,
and Baccarini, M.
(1999)
Infect. Immun.
67,
1011-1017
|
| 56.
|
Kazmierczak, B. I.,
Jou, T. S.,
Mostov, K.,
and Engel, J. N.
(2001)
Cell. Microbiol.
3,
85-98
|
| 57.
|
Salyers, A. A.,
and Whitt, D. D.
(1994)
Bacterial Pathogenesis: A Molecular Approach
, 2nd Ed.
, ASM Press, Washington, D. C.
|
| 58.
|
Chaves-Olarte, E.,
Florin, I.,
Boquet, P.,
Popoff, M.,
von Eichel-Streiber, C.,
and Thelestam, M.
(1996)
J. Biol. Chem.
271,
6925-6932
|
| 59.
|
Anderson, T. D.,
Cheville, N. F.,
and Meador, V. P.
(1986)
Vet. Pathol.
23,
227-239
|
| 60.
|
Anderson, T. D.,
and Cheville, N. F.
(1986)
Am. J. Pathol.
124,
226-237
|
| 61.
|
Hayne, C.,
Tzivion, G.,
and Luo, Z.
(2000)
J. Biol. Chem.
275,
31876-31882
|
| 62.
|
Shtil, A. A.,
Mandlekar, S., Yu, R.,
Walter, R. J.,
Hagen, K.,
Tan, T. H.,
Roninson, I. B.,
and Kong, A. N.
(1999)
Oncogene
18,
377-384
|
| 63.
|
Stone, A. A.,
and Chambers, T. C.
(2000)
Exp. Cell Res.
254,
110-119
|
| 64.
|
Subbaramaiah, K.,
Hart, J. C.,
Norton, L.,
and Dannenberg, A. J.
(2000)
J. Biol. Chem.
275,
14838-14845
|
| 65.
|
Walker, T. S.
(1984)
Infect. Immun.
44,
205-210
|
| 66.
|
Vasselon, T.,
Mounier, J.,
Prevost, M. C.,
Hellio, R.,
and Sansonetti, P. J.
(1991)
Infect. Immun.
59,
1723-1732
|
| 67.
|
Ginocchio, C.,
Pace, J.,
and Galán, J. E.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
5976-5980
|
| 68.
|
Mounier, J.,
Vasselon, T.,
Hellio, R.,
Lesourd, M.,
and Sansonetti, P. J.
(1992)
Infect. Immun.
60,
237-248
|
| 69.
|
Francis, C. L.,
Ryan, T. A.,
Jones, B. D.,
Smith, S. J.,
and Falkow, S.
(1993)
Nature
364,
639-642
|
| 70.
|
Bermúdez, L. E.,
and Young, L. S.
(1994)
Infect. Immun.
62,
2021-2026
|
| 71.
|
Plotkowski, M. C.,
Saliba, A. M.,
Pereira, S. H.,
Cervante, M. P.,
and Bajolet-Laudinat, O.
(1994)
Infect. Immun.
62,
5456-5463
|
| 72.
|
Adam, T.,
Arpin, M.,
Prevost, M. C.,
Gounon, P.,
and Sansonetti, P. J.
(1995)
J. Cell Biol.
129,
367-381
|
| 73.
|
Coxon, P. Y.,
Summersgill, J. T.,
Ramirez, J. A.,
and Miller, R. D.
(1998)
Infect. Immun.
66,
2905-2913
|
| 74.
|
Kespichayawattana, W.,
Rattanachetkul, S.,
Wanun, T.,
Utaisincharoen, P.,
and Sirisinha, S.
(2000)
Infect. Immun.
68,
5377-5384
|
| 75.
|
Linder, S.,
Heimerl, C.,
Fingerle, V.,
Aepfelbacher, M.,
and Wilske, B.
(2001)
Infect. Immun.
69,
1739-1746
|
| 76.
|
Oelschlaeger, T. A.,
Guerry, P.,
and Kopecko, D. J.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
6884-6888
|
| 77.
|
Richardson, W. P.,
and Sadoff, J. C.
(1988)
Infect. Immun.
56,
2512-2514
|
| 78.
|
St. Geme, J. W., III,
and Falkow, S.
(1990)
Infect. Immun.
58,
4036-4044
|
| 79.
|
Francis, C. L.,
Jerse, A. E.,
Kaper, J. B.,
and Falkow, S.
(1991)
J. Infect. Dis.
164,
693-703
|
| 80.
|
Janda, J. M.,
Abbott, S. L.,
and Oshiro, L. S.
(1991)
Infect. Immun.
59,
154-161
|
| 81.
|
Lamont, R. J.,
Chan, A.,
Belton, C. M.,
Izutsu, K. T.,
Vasel, D.,
and Weinberg, A.
(1995)
Infect. Immun.
63,
3878-3885
|
| 82.
|
Miliotis, M. D.,
Tall, B. D.,
and Gray, R. T.
(1995)
Infect. Immun.
63,
4959-4963
|
| 83.
|
Meier, C.,
Oelschlaeger, T. A.,
Merkert, H.,
Korhonen, T. K.,
and Hacker, J.
(1996)
Infect. Immun.
64,
2391-2399
|
| 84.
|
Meyer, D. H.,
Rose, J. E.,
Lippmann, J. E.,
and Fives-Taylor, P. M.
(1999)
Infect. Immun.
67,
6518-6525
|
| 85.
|
Krendel, M.,
Sgourdas, G.,
and Bonder, E. M.
(1998)
Cell Motil. Cytoskeleton
40,
368-378
|
| 86.
|
Rochlin, M. W.,
Dailey, M. E.,
and Bridgman, P. C.
(1999)
Mol. Biol. Cell
10,
2309-2327
|
| 87.
|
Waterman-Storer, C. M.,
Worthylake, R. A.,
Liu, B. P.,
Burridge, K.,
and Salmon, E. D.
(1999)
Nat. Cell Biol.
1,
45-50
|
| 88.
|
Nobes, C. D.,
and Hall, A.
(1995)
Cell
81,
53-62
|
| 89.
|
Keely, P. J.,
Westwick, J. K.,
Whitehead, I. P.,
Der, C. J.,
and Parise, L. V.
(1997)
Nature
390,
632-636
|
| 90.
|
Sander, E. E.,
van Delft, S.,
ten Klooster, J. P.,
Reid, T.,
van der Kammen, R. A.,
Michiels, F.,
and Collard, J. G.
(1998)
J. Cell Biol.
143,
1385-1398
|
| 91.
|
Kodaki, T.,
Woscholski, R.,
Hallberg, B.,
Rodríguez-Viciana, P.,
Downward, J.,
and Parker, P. J.
(1994)
Curr. Biol.
4,
798-806
|
| 92.
|
Jullien-Flores, V.,
Mahe, Y.,
Mirey, G.,
Leprince, C.,
Meunier-Bisceuil, B.,
Sorkin, A.,
and Camonis, J. H.
(2000)
J. Cell Sci.
113,
2837-2844
|
| 93.
|
Nakashima, S.,
Morinaka, K.,
Koyama, S.,
Ikeda, M.,
Kishida, M.,
Okawa, K.,
Iwamatsu, A.,
Kishida, S.,
and Kikuchi, A.
(1999)
EMBO J.
18,
3629-3642
|
| 94.
|
Pizon, V.,
Desjardins, M.,
Bucci, C.,
Parton, R. G.,
and Zerial, M.
(1994)
J. Cell Sci.
107,
1661-1670
|
| 95.
|
Hu, L.,
and Kopecko, D. J.
(1999)
Infect. Immun.
67,
4171-4182
|
| 96.
|
Velge, P.,
Bottreau, E.,
Van Langendonck, N.,
and Kaeffer, B.
(1997)
J. Med. Microbiol.
46,
681-692
|
| 97.
|
Ridley, A. J.,
Paterson, H. F.,
Johnston, C. L.,
Diekmann, D.,
and Hall, A.
(1992)
Cell
70,
401-410
|
| 98.
|
Sander, E. E.,
ten Klooster, J. P.,
van Delft, S.,
van der Kammen, R. A.,
and Collard, J. G.
(1999)
J. Cell Biol.
147,
1009-1022
|
| 99.
|
Kuhn, M.
(1998)
FEMS Microbiol. Lett.
160,
87-90
|
| 100.
|
Wells, C. L.,
van de Westerlo, E. M.,
Jechorek, R. P.,
Haines, H. M.,
and Erlandsen, S. L.
(1998)
Infect. Immun.
66,
2410-2419
|
| 101.
|
Finlay, B. B.,
and Falkow, S.
(1988)
Biochimie (Paris)
70,
1089-1099
|
| 102.
|
Oelschlaeger, T. A.,
and Tall, B. D.
(1997)
Infect. Immun.
65,
2950-2958
|
| 103.
|
Finlay, B. B.,
Ruschkowski, S.,
and Dedhar, S.
(1991)
J. Cell Sci.
99,
283-296
|
| 104.
|
García-del Portillo, F.,
Pucciarelli, M. G.,
Jefferies, W. A.,
and Finlay, B. B.
(1994)
J. Cell Sci.
107,
2005-2020
|
| 105.
|
Gaillard, J. L.,
Berche, P.,
Mounier, J.,
Richard, S.,
and Sansonetti, P.
(1987)
Infect. Immun.
55,
2822-2829
|
| 106.
|
Tang, P.,
Rosenshine, I.,
and Finlay, B. B.
(1994)
Mol. Biol. Cell
5,
455-464
|
| 107.
|
Drevets, D. A.
(1998)
Infect. Immun.
66,
232-238
|
| 108.
|
Tang, P.,
Sutherland, C. L.,
Gold, M. R.,
and Finlay, B. B.
(1998)
Infect. Immun.
66,
1106-1112
|
| 109.
|
Wilson, S. L.,
and Drevets, D. A.
(1998)
J. Infect. Dis.
178,
1658-1666
|
| 110.
|
Eaves-Pyles, T.,
Szabo, C.,
and Salzman, A. L.
(1999)
Infect. Immun.
67,
800-804
|
| 111.
|
Velge, P.,
Bottreau, E.,
Kaeffer, B.,
Yurdusev, N.,
Pardon, P.,
and Van Langendonck, N.
(1994)
Microb. Pathog.
17,
37-50
|
| 112.
|
Rosenshine, I.,
Duronio, V.,
and Finlay, B. B.
(1992)
Infect. Immun.
60,
2211-2217
|
| 113.
|
Kugler, S.,
Schuller, S.,
and Goebel, W.
(1997)
FEMS Microbiol. Lett.
157,
131-136
|
| 114.
|
Wells, C. L.,
Jechorek, R. P.,
Kinneberg, K. M.,
Debol, S. M.,
and Erlandsen, S. L.
(1999)
J. Nutr.
129,
634-640
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. V. Delpino, C. A. Fossati, and P. C. Baldi
Proinflammatory Response of Human Osteoblastic Cell Lines and Osteoblast-Monocyte Interaction upon Infection with Brucella spp.
Infect. Immun.,
March 1, 2009;
77(3):
984 - 995.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Manterola, C. Guzman-Verri, E. Chaves-Olarte, E. Barquero-Calvo, M.-J. de Miguel, I. Moriyon, M.-J. Grillo, I. Lopez-Goni, and E. Moreno
BvrR/BvrS-Controlled Outer Membrane Proteins Omp3a and Omp3b Are Not Essential for Brucella abortus Virulence
Infect. Immun.,
October 1, 2007;
75(10):
4867 - 4874.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. He, S. Reichow, S. Ramamoorthy, X. Ding, R. Lathigra, J. C. Craig, B. W. S. Sobral, G. G. Schurig, N. Sriranganathan, and S. M. Boyle
Brucella melitensis Triggers Time-Dependent Modulation of Apoptosis and Down-Regulation of Mitochondrion-Associated Gene Expression in Mouse Macrophages
Infect. Immun.,
September 1, 2006;
74(9):
5035 - 5046.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Jimenez de Bagues, A. Gross, A. Terraza, and J. Dornand
Regulation of the Mitogen-Activated Protein Kinases by Brucella spp. Expressing a Smooth and Rough Phenotype: Relationship to Pathogen Invasiveness
Infect. Immun.,
May 1, 2005;
73(5):
3178 - 3183.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P. Marini, N. S. Taylor, A. Y. Liang, K. A. Knox, J. A. Pena, D. B. Schauer, and J. G. Fox
Characterization of Hemolytic Escherichia coli Strains in Ferrets: Recognition of Candidate Virulence Factor CNF1
J. Clin. Microbiol.,
December 1, 2004;
42(12):
5904 - 5908.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Subtil, B. Wyplosz, M. E. Balana, and A. Dautry-Varsat
Analysis of Chlamydia caviae entry sites and involvement of Cdc42 and Rac activity
J. Cell Sci.,
August 1, 2004;
117(17):
3923 - 3933.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Drevets, P. J. M. Leenen, and R. A. Greenfield
Invasion of the Central Nervous System by Intracellular Bacteria
Clin. Microbiol. Rev.,
April 1, 2004;
17(2):
323 - 347.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Pei and T. A. Ficht
Brucella abortus Rough Mutants Are Cytopathic for Macrophages in Culture
Infect. Immun.,
January 1, 2004;
72(1):
440 - 450.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Lestrate, A. Dricot, R.-M. Delrue, C. Lambert, V. Martinelli, X. De Bolle, J.-J. Letesson, and A. Tibor
Attenuated Signature-Tagged Mutagenesis Mutants of Brucella melitensis Identified during the Acute Phase of Infection in Mice
Infect. Immun.,
December 1, 2003;
71(12):
7053 - 7060.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Gross, M. Bouaboula, P. Casellas, J.-P. Liautard, and J. Dornand
Subversion and Utilization of the Host Cell Cyclic Adenosine 5'-Monophosphate/Protein Kinase A Pathway by Brucella During Macrophage Infection
J. Immunol.,
June 1, 2003;
170(11):
5607 - 5614.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Guzman-Verri, L. Manterola, A. Sola-Landa, A. Parra, A. Cloeckaert, J. Garin, J.-P. Gorvel, I. Moriyon, E. Moreno, and I. Lopez-Goni
The two-component system BvrR/BvrS essential for Brucellaabortus virulence regulates the expression of outer membrane proteins with counterparts in members of the Rhizobiaceae
PNAS,
September 17, 2002;
99(19):
12375 - 12380.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Moreno and I. Moriyon
Brucella melitensis: A nasty bug with hidden credentials for virulence
PNAS,
January 8, 2002;
99(1):
1 - 3.
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|